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Lifespan-increasing drug nordihydroguaiaretic acid inhibits
p300 and activates autophagy
Tugsan Tezil 1, Manish Chamoli 1, Che-Ping Ng1, Roman P. Simon2, Victoria J. Butler3, Manfred Jung 2, Julie Andersen1,
Aimee W. Kao 3 and Eric Verdin 1*
Aging is characterized by the progressive loss of physiological function in all organisms. Remarkably, the aging process can be
modulated by environmental modifications, including diet and small molecules. The natural compound nordihydroguaiaretic acid
(NDGA) robustly increases lifespan in flies and mice, but its mechanism of action remains unclear. Here, we report that NDGA is an
inhibitor of the epigenetic regulator p300. We find that NDGA inhibits p300 acetyltransferase activity in vitro and suppresses
acetylation of a key p300 target in histones (i.e., H3K27) in cells. We use the cellular thermal shift assay to uniquely demonstrate
NDGA binding to p300 in cells. Finally, in agreement with recent findings indicating that p300 is a potent blocker of autophagy, we
show that NDGA treatment induces autophagy. These findings identify p300 as a target of NDGA and provide mechanistic insight
into its role in longevity.
npj Aging and Mechanisms of Disease             (2019) 5:7 ; https://doi.org/10.1038/s41514-019-0037-7
INTRODUCTION
Aging is associated with an increase in age-related diseases that
include many cancers, neurodegenerative diseases (e.g., Parkin-
son’s and Alzheimer’s), atherosclerosis and associated cardiovas-
cular disorders (e.g., heart attacks and stroke), macular
degeneration, osteoarthritis, and sarcopenia.1 Remarkably, aging
or its manifestations as chronic diseases of aging can be slowed by
a number of interventions that include diet, exercise, and
pharmaceutical drugs.2 The Interventions Testing Program at the
National Institute on Aging has tested 27 drugs for their effects on
lifespan in mice. They identified six drugs, including rapamycin,
aspirin, acarbose, nordihydroguaiaretic acid (NDGA), protandim,
and 17α-estradiol, that were associated with increased median
lifespan.3–6 In particular, NDGA showed a consistent median
lifespan extension by 8–10% at three different doses in mice,
particularly in males. Old mice (22 months old) treated with NDGA
showed improved grip duration and rotarod performance,
indicating better muscle function than untreated age-matched
animals. NDGA also extends median lifespan in evolutionarily
distant organisms, such as fruit flies (by 12%) and mosquitoes (by
50%).7,8 Several studies also showed the effects of NDGA on
neurodegenerative disorders. In a fruit fly model of Parkinson’s
disease, NDGA delayed the loss of climbing ability associated with
onset of neurodegeneration.9 NDGA also decreased motor
dysfunction in a mouse model of amyotrophic lateral sclerosis
and extended lifespan by 10% in this context.10 Furthermore,
NDGA restored synapse structure and extended lifespan by 19% in
a mouse model of Huntington’s disease11 and decreased amyloid-
beta deposition in the brains of mouse models of Alzheimer’s
disease.12,13
In vitro studies show that NDGA scavenges hydroxyl radical,
peroxynitrite, superoxide anion and singlet oxygen, suggesting
that NDGA might function as an antioxidant agent.14,15 In vivo,
NDGA exerts cytoprotective effects by modulating the nuclear
factor erythroid 2-related factor 2 (Nrf2)/antioxidant response
element (ARE) antioxidant pathway.16 This variety of effects makes
NDGA a compelling candidate for further study in the context of
aging and geroprotective processes.
The hallmarks of aging include epigenetic alterations and
deregulation of nutrient sensing.1 Levels of histone acetylation
change during aging and are related to increased acetyl-CoA
levels in aging animals,17 and acetyl-CoA levels decrease
significantly upon calorie restriction even before cellular ATP,
NADH, or amino acid levels are affected.18,19 As acetyl-CoA is the
only acetyl-group donor for protein acetylation reactions, its
cellular level highly influences the activity of acetyltransferases.20
Particularly, histone and nonhistone acetyltransferase p300 (E1A-
associated protein p300) functions as a molecular sensor of
changes in cellular and possibly other acyl-CoA levels as well.21
Any decrease in cellular acetyl-CoA significantly limits the activity
of p300 and decreases subsequent acetylation reactions involving
key cellular proteins.22,23 Notably, p300 potently blocks autophagy
by acetylating autophagy-related proteins including Atg5, Atg7,
Atg12, and LC3.24
Although the health benefits of NDGA have been demonstrated
in different organisms and conditions, its underlying mechanism
of action remains unclear. Early reports show that NDGA inhibits
arachidonic acid 5-lipoxygenase,25 which catalyzes the first step in
leukotriene A4 biosynthesis, and lysophosphatidylcholine
acyltransferase-2 (LPCAT2),26 an enzyme in platelet-activating
factor (PAF) biosynthesis that converts the precursor lyso-PAF (1-
O-alkyl-sn-glycero-3-phosphocholine) into active PAF (1-O-alkyl-2-
acetyl-sn-glycero-3-phosphocholine) by acetylation. Interestingly,
salicylate (an active metabolite of aspirin) and diflunisal (a
salicylate derivative) both also inhibit LPCAT2.27
We recently reported that both salicylate and diflunisal are
inhibitors of the histone acetyltransferase p300.28 Here we tested
the possibility that NDGA also inhibits p300 and exerts its effect on
aging by inhibition of this important epigenetic regulator. We
report that NDGA inhibits p300. We further present evidence of
NDGA directly binding to p300 in cells and show that NDGA
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treatment activates the autophagy pathway and promotes
autophagosome formation in human cells, as well as in C. elegans.
RESULTS
NDGA inhibits p300 in vitro
To test the hypothesis that NDGA is a p300 inhibitor, we used two
different in vitro enzymatic assays that measure the acetyltrans-
ferase activities of p300 and PCAF (p300/CBP-associated factor). In
the first assay, we used purified human recombinant p300 BHC
protein29 (a construct containing the bromodomain, catalytic
acetyltransferase domain, and C/H3 domain, amino acids
965–1810) that represents the acetyltransferase activity of full
length protein,30 histone H3 (amino acids 1–21) peptide as a
substrate, and acetyl-CoA as an acetyl-group donor, to measure
the activity of p300 on histone H3 in the presence of NDGA. In this
fluorimetric assay, NDGA inhibited p300 BHC with an IC50 of
10.3 μM, compared with 75 μM for the known p300 inhibitor
anacardic acid31 (Fig. 1a). When we evaluated NDGA for the
inhibition of human recombinant PCAF HAT (histone acetyltrans-
ferase domain), we observed no inhibition even at high
concentrations of NDGA (Fig. 1b), ruling out a nonspecific
mechanism of action. In the second assay, we used purified
human recombinant p300 HAT protein consisting of the core HAT
only (amino acids 1284–1673), histone H3 peptide (amino acids
1–21), and acetyl–CoA mixture in reaction buffer containing
increasing concentrations of NDGA. Consistent with Fig. 1a, b,
NDGA inhibited p300 HAT activity (Fig. 1c) but failed to inhibit
purified human PCAF HAT activity (Fig. 1d). To further understand
the mechanism of p300 inhibition, we determined inhibition
kinetics of p300 HAT activity by NDGA for both substrates acetyl-
CoA and H3 peptide. Double-reciprocal plots were constructed to
find the nature of inhibition. Inhibition kinetics studies clearly
showed that NDGA is a noncompetitive inhibitor for both acetyl-
CoA (Fig. 1e) and histone H3 binding sites (Fig. 1f). These results
indicate that NDGA is a selective inhibitor of p300 acetyltransfer-
ase activity in vitro.
NDGA inhibits p300-mediated histone acetylation in human,
mouse and fruit fly cells
As an epigenetic regulator, p300 orchestrates gene expression via
acetylation of specific lysine residues in specific cellular histone
proteins in cells.32 To determine whether NDGA influences histone
acetyl marks in cells, we monitored the acetylation status of
different lysine residues in HEK293T cells treated with NDGA.
Specifically, we extracted the histones and conducted western
blot analysis using antibodies selective for unique acetylated
histone residues and determined IC50 values for each residue (Fig.
2a, Supplementary Fig. 1). Previous genetic studies reported that
deletion of p300 specifically reduces acetylation on H3K27 but not
H3K9.33 Consistent with our hypothesis that NDGA selectively
inhibits p300 in cells, we found that histone H3K27 acetylation was
the most suppressed in cells treated with NDGA with an IC50 of
8.8 μM (Fig. 2a–c). The acetylation of other histone residues was
also suppressed but in most cases with IC50 > 25 μM, except for
H3K14 (Fig. 2a). As expected, residues that are not p300 targets,
such as H3K9, were unchanged by NDGA (Fig. 2a–c).
To test the effect of NDGA on H3K27 acetylation in different
organisms, we also treated mouse (MEF) and fruit fly (S2
Schneider) cell lines with NDGA (30 μM) for 24 h, and analyzed
extracted histones by immunoblotting. As with HEK293T, H3K27
acetylation was also found to be decreased also in these cell lines
upon NDGA treatment (Fig. 2d, Supplementary Fig. 2), demon-
strating the suppressive effect of NDGA on H3K27 acetylation in
evolutionarily distant organisms.
NDGA-induced suppression of H3K27ac is associated with
increased tri-methylation of the same residue in HEK293T cells
Decreased histone H3 K27 tri-methylation (H3K27me3) is a
characteristic hallmark of aging in both invertebrates and
vertebrates. Worms and fruit flies exhibit an age-associated
decrease in H3K27me3 marks,34 but in humans, a strong decrease
in this modification has been observed in primary fibroblasts from
patients with Hutchinson–Gilford progeria syndrome, a premature
aging disease.35 Conversely, the naked mole rat, which is the
longest-living rodent with a lifespan of more than 28 years,36
bears higher levels of H3K27 tri-methylation compared to mice.37
Since acetylation and methylation are mutually exclusive on a
single lysine, decreased acetylation can result in an increase in
methylation on the same residue.38 Therefore, we treated
HEK293T cells with increasing concentrations of NDGA, extracted
histones, and determined the methylation status of H3K27 by
immunoblotting. As predicted and in agreement with the
decrease in H3K27 acetylation, cells treated with NDGA showed
a significant increase in H3K27 tri-methylation with a half maximal
effective concentration (EC50) of 9.80 μM (Fig. 2a–c).
Fig. 1 NDGA inhibits histone acetyltransferase activity of p300
in vitro. a The acetyltransferase activity of p300 on histone H3
peptide (aa 1–21) was measured in the presence of NDGA or
anacardic acid. Results are expressed as percentage activity in the
absence of NDGA. A paired t-test was performed for statistical
significance, p= 0.0013. b Effect of NDGA on PCAF HAT activity
expressed as percentage activity in the absence of NDGA. Inhibitory
effects of NDGA on p300 (c) and PCAF (d) using another enzymatic
assay were measured and are expressed as percentage inhibition
relative to control DMSO. Effects of varying concentrations of acetyl-
CoA (e) and substrate peptide histone H3 in the presence of varying
concentrations of NDGA were measured (f). Data represent the
results from three independent experiments (mean ± S.D.), and
curves were generated using nonlinear regression fit
T. Tezil et al.
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Fig. 2 NDGA inhibits p300-driven histone acetylation in HEK293T cells. a Median inhibitory concentration (IC50) values for NDGA on different
acetylated histone residues and median effective concentration (EC50) value on H3K27 tri-methylation were determined by immunoblotting of
histones extracted from cells after 24-h treatments with varying concentrations of NDGA (ND, not determined). b Differences in acetylation
and tri-methylation of p300 target (H3K14, H3K18, and H3K27) and non-target (H3K9) histones were monitored by immunoblotting after
indicated concentrations of NDGA treatment for 24 h and histone extraction. c Dose-dependent changes in acetylation and tri-methylation on
H3K27 after 24-h NDGA treatment were analyzed by immunoblotting and are represented as percentage change in histone modification
relative to DMSO treatment. d Decreases in H3K27 acetylation upon 30 µM of NDGA treatment for 24 h in human (HEK293T), mouse (MEF) and
fruit fly (S2 Schneider) cells were monitored by immunoblotting after histone extraction. e. Effects of wildtype p300 overexpression on NDGA-
dependent H3K27 hypoacetylation were determined by densitometric analysis of immunoblotting data. Cells were transfected with different
amounts of human wildtype EP300 encoding expression plasmid pCI-p300(WT) and/or empty vector (EV) and treated with varying NDGA
concentrations for 24 h. The data represent percentage change in H3K27 acetylation relative to DMSO treatment and the change in IC50
values. f The rescue of p300 overexpression on H3K27 hypoacetylation after 30 µM NDGA treatment was performed as in panel E. g Effects of
overexpression of wildtype and catalytically inactive p300 mutants (Y1503A and F1504A) on NDGA-induced H3K27 hypoacetylation were
determined by immunoblotting and densitometry. Cells were transfected by the same amount of expression plasmids or empty vector (EV)
and treated with varying NDGA concentrations. Histones were extracted and analyzed. h The effects of wildtype and mutant (Y1503A or
F1504A) p300 overexpression on NDGA-induced histone hypoacetylation and hypermethylation were determined by immunoblotting after
30 µM NDGA treatment for 24 h. i Effects of wildtype and mutant p300 overexpression on NDGA-induced histone hypoacetylation were
analyzed by immunoblotting and densitometry. j Decreased H3K27 tri-methylation upon wildtype p300 overexpression was detected by
immunoblotting and densitometry. Total histone antibodies were used as loading controls in all experiments. Data represent the results from
two independent experiments (mean ± S.D.) and curves were generated using nonlinear regression fit
T. Tezil et al.
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Overexpression of p300 reverses NDGA-induced loss of H3K27
acetylation
To further assess p300 as a relevant target of NDGA, we
overexpressed different amounts of full-length p300 in
HEK293T cells and treated them with NDGA. In support of a role
for p300 in sustaining H3K27 acetylation, we found that over-
expression of p300 suppressed the effect of NDGA in a dose-
dependent manner and increased H3K27 acetylation (Fig. 2e,
Supplementary Fig. 3). The IC50 of NDGA in rescue experiments
was strongly correlated with the amount of p300-expressing
plasmid transfected (Fig. 2f, Supplementary Table 1). Furthermore,
addition of catalytically inactive p300 mutants (p300Y1503A and
F1504A)39 failed to revert NDGA-mediated inhibition (Fig. 2g,
Supplementary Fig. 3). In addition to H3K27 acetylation, we also
evaluated the acetylation of other histone residues with an IC50
lower than 50 μM (H3K4, H3K14, H3K18, H2AK13). While we
observed a significant rescue effect on H3K27 and a slight rescue
in H3K4 acetylation with wildtype p300 overexpression, changes
in other acetylated residues were insignificant (Fig. 2h, i,
Supplementary Fig. 4). In agreement with our previous result,
we observed a significant decrease in H3K27 tri-methylation when
wildtype p300 was overexpressed; whereas overexpression of
mutant p300 was unable to change the levels of H3K27me3
(Fig. 2j, Supplementary Fig. 4). These findings support the
hypothesis that NDGA-mediated H3K27 hypoacetylation and
elevated H3K27 tri-methylation are specifically due to inhibition
of p300 acetyltransferase activity.
p300 is a direct target of NDGA in HEK293T cells
To provide additional evidence that NDGA directly binds to p300
in cells, we used a cellular thermal shift assay (CETSA) that
uniquely allows monitoring of drug engagement inside cells.40
Based on the principle of ligand-induced protein stabilization,
compound-bound proteins precipitate at higher temperatures
than unbound proteins and can be detected at higher levels in the
soluble fraction. To identify direct targets of NDGA, we tested
different acetyltransferases. We exogenously expressed p300 HAT
(p300/CBP family), GCN5 (general control of amino acid synthesis
protein 5-like 2) and PCAF (GNAT family), and TIP60 (60-kDa Tat-
interactive protein, MYST family) in HEK293T cells and treated the
cells with NDGA. Intact cells were heated at different temperatures
for 3 min to denature and precipitate proteins. These cells were
then subjected to three freeze-thaw cycles to lyse them, isolation
of a soluble fraction after centrifugation (20,000 × g) and analysis
by immunoblotting. We observed an increase in the thermo-
stability of p300 HAT domain by 10.8 °C upon NDGA treatment
(Fig. 3a, Supplementary Fig. 5). To confirm this thermostabilization
in a dose-dependent manner, we treated cells with different
concentrations of NDGA and heated them at a single temperature
(55 °C) where we previously detected 35% of the total amount of
p300 in the soluble fraction. Maximal stabilization (100%) occurred
at 30 μM NDGA (Fig. 3b, Supplementary Fig. 5). Importantly, CETSA
analysis of GCN5, PCAF, and TIP6 (Fig. 3c–e, Supplementary Fig. 5)
showed no significant change in thermostability upon NDGA
treatment. The difference in melting temperatures (Tm) of proteins
tested are shown in Fig. 3f. These results further support the
model that NDGA specifically binds to p300 HAT at a concentra-
tion consistent with its inhibitory activity on histone acetylation
(Fig. 2).
NDGA induces autophagy in HEK293T and HeLa cells
While we demonstrated a potential molecular mechanism for the
role of NDGA in aging cells above, the cellular mechanism by
which NDGA elicits these effects remains unexplored. p300, the
molecular target of NDGA, is a regulator of cellular autophagy, an
evolutionarily conserved process for efficient removal of damaged
and potentially harmful cellular contents, including long-lived
proteins and cellular organelles.41 To accomplish this cellular
cleansing effort, the coordinated actions of various autophagy-
related (Atg) proteins are required. Atg proteins provide the main
molecular machinery essential for initiating autophagosome
formation via an ubiquitin-like conjugation system.42 Interestingly,
p300 modulates the acetylation status of several Atg proteins.
Silencing of p300 expression reduces the acetylation of Atg5,
Atg7, LC3, and Atg12, and increases their stability and cellular
level, resulting in autophagy pathway activation. Overexpression
of p300, on the other hand, causes a significant increase in
acetylation, decreases the stability of mentioned key proteins, and
consequently blocks autophagy by lowering their cellular level.
These previous results predict that inhibiting p300 by NDGA could
act through activating autophagy. To test this hypothesis, we
measured the level of autophagy after NDGA treatment and in
response to serum-free media as a positive control. Adding NDGA
to HEK293T cells induced several molecular markers of autophagy,
including AMPK phospho-activation and upregulation of Beclin-1
(Fig. 4a, Supplementary Fig. 6).
Fig. 3 NDGA is a target of NDGA in HEK293T cells. a Melting curves
of the p300 HAT domain were generated from a CETSA experiment
performed in intact cells expressing HA tagged p300-HAT construct
following 3-h DMSO or NDGA treatment. b Isothermal dose-
response fingerprint-CETSA (ITDRFCETSA) graph was generated from
cells expressing the p300-HAT construct. Intact cells were treated
with different concentrations of NDGA for 3 h and subjected to
heating at 55 °C for 3 min to monitor thermostabilization. Melting
curves of different acetyltransferases were generated from intact
cells expressing HA-GCN5 (c), HA-PCAF (d) or HA-TIP60 (e) after 3-h
DMSO or 30 µM NDGA treatment and CETSA. f Change in melting
temperatures (Tm) of tested proteins upon NDGA treatment. Data
represent the results from two independent experiments (mean ± S.D.),
and curves were generated using nonlinear regression fit
T. Tezil et al.
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Atg proteins together regulate the formation of a double
membrane structure (autophagosome) that engulfs the cellular
cargo targeted for degradation.43 Briefly, Atg7 induces Atg12-Atg5
conjugation and this conjugate specifies localization of LC3 on the
lipid membrane. Our results showed a dose-dependent increase in
Atg7 levels, and an increase in Atg5/Atg12 dimerization (Fig. 4a,
Supplementary Fig. 6), consistent with induction of autophagy. In
addition, we observed upregulation of LC3-II, which is associated
with autophagosome formation as well as upregulation of the
autophagy cargo receptors NBR1 (Neighbor of BRCA1 gene 1) and
p62 (SQSTM1, Sequestosome-1) upon treatment with NDGA (Fig.
4a, Supplementary Fig. 6). To confirm the induction of autophagy
T. Tezil et al.
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in cells, we visualized the process by imaging HeLa cells stably
expressing GFP-LC3. Following a 24-h treatment with NDGA
(30 μM) or DMSO, we analyzed LC3 lipidation. LC3-positive puncta
were significantly increased with NDGA treatment. Moreover,
treatment with Bafilomycin A1, an V-ATPase inhibitor that
prevents the fusion of autophagosomes and lysosomes,44 or with
the lysosomal pH-neutralizing compound Chloroquine45 resulted
in an additional increase in GFP-LC3 puncta in treated cells (Fig.
4b, e). These results indicate the accumulation of autophago-
somes demonstrating that HeLA-GFP-LC3 cells have a functional
autophagy pathway. An increase in autophagosome number upon
NDGA treatment caused a rise in the number of cells undergoing
autophagy (Fig. 4c, e). We also observed that the pro-autophagic
effect of NDGA was dose-dependent (Fig. 4d, Supplementary Fig.
7). NDGA-treated HEK293T cells showed increased levels of
endogenous NBR1, p62, and LC3-II upon NDGA treatment;
Bafilomycin A or Chloroquine treatment further enhanced this
effect (Fig. 4f, Supplementary Fig. 6). Since the overexpression of
p300 rescues H3K27 hypoacetylation (Fig. 2f), we next evaluated
p62 and LC3-II levels in wildtype versus mutant p300 over-
expressing HEK293T cells upon NDGA treatment. Figure 4g shows
the rescue effect of excess p300 expression by downregulation of
these autophagy markers (Supplementary Fig. 6). When we
compared NDGA with other p300 inhibitors C646 and A485 for
autophagy induction, we discovered that these inhibitors also
increased the levels of autophagy markers NBR1, p62, and LC3-II in
HEK293T cells (Fig. 4h, Supplementary Fig. 6). These data indicate
that NDGA effectively increases autophagic flux in HEK293T and
GFP-LC3 HeLa cells, and that p300 activity is a key element in
NDGA-induced autophagy.
NDGA increases median lifespan, decreases histone acetylation,
and induces autophagy in worms
To determine the prolongevity property of NDGA in vivo, we
treated wildtype C. elegans (N2 Bristol) with 100 μM NDGA. The
median lifespan of worms exposed to NDGA was 21.4% greater
than that of worms exposed to the vehicle alone (DMSO) (Fig. 5a).
To rule out potential variations in food availability caused by
NDGA, we examined the effect of NDGA on feeding bacteria
(OP50) and found that OP50 growth was unaffected by NDGA (Fig.
5b). These findings indicate that NDGA has a beneficial effect on C.
elegans lifespan that is independent of the feeding bacteria
growth.
CBP-1, the nematode orthologue of p300/CBP, is responsible for
histone acetylation in C. elegans, and animals with catalytically
inactive cbp-1 have decreased global histone acetylation.46 With
this knowledge, we evaluated the possible suppressive effect of
NDGA on histone H3 acetylation. We treated worms with 100 μM
NDGA for 24 h, analyzed histone H3 acetylation by
immunoblotting and observed a significant decrease in histone
H3 acetylation in treated animals (Fig. 5c, d, Supplementary Fig. 8).
To analyze autophagy induction in worms in depth, we used
described reporter strain (MAH215) expressing pH sensitive GFP in
a tandem lgg-1p::mCherry::GFP::lgg-1 in which mCherry puncta
indicates autophagosomes and autolysosomes.47 Worms exposed
to NDGA had an increase in mCherry-only puncta, indicating an
elevated autophagic activity as assessed by increased fusion of
autophagosomes to lysosomes (Fig. 5e, g). MAH215 worms with
this tandem reporter allow us to analyze the autophagosome
maturation process by monitoring the GFP and mCherry
fluorescence intensity over time. Increased autophagic flux and
lysosomal activity following NDGA treatment is also evident from
observed decreases in pH-sensitive GFP fluorescence over time
resulting from the quenching of GFP within the acidic lysosome.
We examined the NDGA-treated worms (2–24 h) by measuring the
ratio of GFP relative to mCherry fluorescence. We observed that
GFP signal was significantly less in animals treated for 2 h than in
the vehicle-treated animals (DMSO), and those levels continued to
decrease at 24 h (Fig. 5f). In agreement with these results, worms
treated with NDGA also show increased lysotracker staining,
suggesting an increased number of lysosomes/late endosomes
most likely as a result of increased autophagic activity (Fig. 5h, i).
These data provide evidence that NDGA treatment causes an
increase in autophagic flux in C. elegans.
DISCUSSION
Here we present evidence for a potential mechanism for NDGA
actions as a lifespan increasing drug. We showed that NDGA
effectively inhibits p300 histone acetyltransferase activity in vitro,
and it directly binds the p300 HAT domain and alters several
epigenetic marks associated with aging in human, mouse, and
fruit fly cells. Notably, while we identify p300 as a target of NDGA,
we cannot exclude the possibility that it blocks the activity of
other acetyltransferases. For example, CREBBP (CBP), which shares
high levels of homology with the p300 catalytic domain, is likely to
be also targeted by NDGA. But importantly, NDGA failed to
enhance the thermostability of GNAT family members PCAF and
GCN5 and the MYST family member TIP60 in CETSA experiments.
p300/CBP is conserved in different organisms from nematodes
to mammals and plays an essential role in cell and organism
viability. Worms with inactive CBP-1, knockout of dCBP (the fruit
fly homolog of p300/CBP), and homozygous p300 or CBP
knockout mice demonstrate embryonic lethal phenotypes.48,49
These observations indicate that the use of potent pharmacologic
inhibitors of p300 in clinic might cause unintended toxicity in
younger animals. Therefore, p300 inhibition may be more
applicable during late adulthood or for the treatment of age-
related diseases that rely on elevated p300 activity such as cancer
Fig. 4 NDGA induces autophagy in HEK293T and HeLa cells. a Activation of the autophagy signaling pathway was monitored by
immunoblotting of total proteins isolated from HEK293T cells after a 24-hour treatment with DMSO or varying concentrations of NDGA.
Serum-free medium (SFM) was used as a positive control of autophagy. b Autophagosome formation in HeLa-GFP-LC3 cells was monitored by
counting GFP-LC3 puncta after a 24-h treatment with DMSO or NDGA, with or without Bafilomycin A1 (BafA, 100 nM) or Chloroquine (Chq,
100 µM) treatment 3 h before sample collection. c The percentage of autophagy was measured in HeLa-GFP-LC3 cells treated with DMSO or
NDGA, with or without Bafilomycin A1 or Chloroquine treatment for 3 h prior to sample collection. The threshold value to determine
autophagy-positive cells was based on previous measurements and DMSO-treated cells; d. Autophagy induction in HeLa-GFP-LC3 cells was
analyzed by FACS after a 24-h treatment with varying NDGA concentrations. e GFP-LC3 puncta (green) in HeLa-GFP-LC3 cells treated with
DMSO or NDGA, with or without Bafilomycin A1 or Chloroquine were captured by confocal microscopy. Cells were fixed after 24-h treatment,
stained with DAPI (blue) and analyzed. f Effects of Bafilomycin A and Chloroquine treatment for 3 h on autophagy marker proteins were
quantitated by immunoblotting following total protein extraction. g Effects of wildtype and mutant (Y1503A and F1504A) p300
overexpression on NDGA-induced autophagy were monitored by immunoblotting. h Effects of p300 inhibitors on H3K27 acetylation and
autophagy induction were analyzed by immunoblotting. HEK293T cells treated with NDGA (100 µM), A485 (100 nM) or C646 (100 µM) for 24 h,
and total protein or histones were extracted. Numbers in immunoblotting images (f–h) indicate the fold change determined by densitometry
analysis. β-Actin and total histone H3 were used as loading controls. Data represent the results from two independent experiments (mean ± S.D.),
and statistical significance was determined by student t-test (*p < 0.05; **p < 0.01, ***p < 0.001, ****p < 0.0001)
T. Tezil et al.
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and neurodegenerative diseases.50,51 Several chemical inhibitors
with varying potency and selectivity for p300 have already been
tested for their potential anticancer properties, including anacar-
dic acid,52 C646,53 and A485.54
Previous studies on NDGA carried out with mice fed diets
containing different doses of NDGA have determined that blood
levels of NDGA in supplemented animals (165 nM) are lower than
those we found to be required to inhibit p300 in cell-free systems
and to activate autophagy in cells. However, it should be noted
that tissue and plasma concentrations of a compound are not
linearly correlated factors. In fact, several studies previously
reported this phenomenon.55,56 The concentration of NDGA in
serum, uptake in different tissues and its intracellular
concentration may vary. Currently, it is unknown how NDGA is
metabolized, which proteins are involved in its cellular uptake in
different tissues, and how NDGA is distributed in the body. These
characteristics of NDGA should be further investigated in different
cells and tissues.
Previous studies on mice indicate a sexual dimorphism in
response to NDGA treatment: males showed an increase in
median lifespan, but females did not. Importantly, this study also
showed that the median lifespan of control female mice is ~10%
higher than males, and that NDGA-treated males demonstrate a
level of benefit similar to the control lifespan curves of females.
Therefore, NDGA may provide beneficial effects in both females
and males, but possible adverse effects in females could prevent
Fig. 5 NDGA increases median lifespan and induces autophagy in worms. a The effect of NDGA on worm lifespan was measured by exposing
N2 worms to DMSO or NDGA (100 µM) on NGM plates. Average values from three independent experiments were plotted as a lifespan curve.
Lower panel indicates the median lifespan of each group as days and percentage; b The effect of NDGA on feeding bacteria (E. coli OP50)
growth was measured spectrophotometrically (A595) every hour for 8 h in LB medium with 100 µM of NDGA or DMSO. c, d Total histone H3
acetylation in worms was measured by immunoblotting after 24-h NDGA (100 µM) or DMSO exposure and total protein extraction. e Changes
in mCherry puncta number in MAH215 worms were monitored by fluorescence microscopy after a 24-h NDGA or DMSO treatment. f Effects of
NDGA treatment on GFP by time were measured by fluorescence microscopy after NDGA or DMSO (Control) treatment for 2 and 24 h and
represented relative to mCherry intensity. g Monitoring of tandem reporter lgg-1p::mCherry::GFP::lgg-1 expressing worms was performed by
fluorescence microscopy. h, i Monitoring Lysotracker Red staining in N2 worms after 24-h treatment with NDGA (100 µM) or DMSO was
performed by fluorescence microscopy, and fluorescence intensity was measured for individual animals in each group. Data represent the
results from three independent experiments (mean ± S.D.), and statistical significance was determined by student t-test (*p < 0.05; **p < 0.01,
***p < 0.001)
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lifespan extension. Moreover, several compounds extend lifespan
differently favoring either sex. For instance, acarbose and 17-α
estradiol show either smaller or no lifespan extension in female
mice, compared to males. Aspirin and rapamycin inhibit inflam-
matory response, which could have a sex-dependent effect in late-
life inflammation.57 Sex difference in autophagy induction has also
been documented and may influence the efficacy of a
compound.58 The dimorphic nature in response to NDGA or other
lifespan-extending compounds still needs to be understood with
further studies.
Activation of autophagy has emerged as an important
intervention against aging and the chronic diseases of aging,
and its inhibition reverses the beneficial effects of anti-aging
interventions in all species investigated to date.59 Importantly,
p300 decreases the stability of Atg5, Atg7, Atg12, and LC3 by
acetylation and functions as an anti-autophagic regulator under
high nutrient conditions. Our findings are in accord with several
reports showing autophagy induction upon inhibition of p300.60
Our results highlight the role of p300 and pharmacological
inhibitors, such as NDGA, in key aging-related molecular and
cellular processes. These observations support the hypothesis that
the suppressor function of p300 on autophagy can also be
regulated pharmacologically.
Moreover, other interventions that increase lifespan, such as
spermidine, aspirin, calorie restriction, and rapamycin, also provide
their beneficial effects in part by inducing autophagy, potentially
through p300 inhibition.61–64 While spermidine and aspirin
directly inhibit p300, calorie restriction diminishes p300 activity
indirectly by lowering cellular acetyl-CoA levels.65 Rapamycin
indirectly inhibits p300 by suppressing mTORC1, which phosphor-
ylates p300 and prevents its intramolecular inhibition, resulting in
autophagy suppression.66 Together with our results, these findings
underscore the significant role of p300 in aging and could
generate renewed interest in evaluating the clinical utility of p300
inhibitors for both aging and age-related diseases.
METHODS
Cell culture
HEK293T (ATCC), HeLa-LC3-GFP, and MEF (ATCC) cells were maintained in
appropriate volume of Dulbecco’s Modified Eagle Medium supplemented
with 10% serum (Serum Plus - II, Sigma), 100 units/mL penicillin and
100 units/mL streptomycin (Corning, VA). Schneider’s Drosophila Line 2 (S2
Schneider) was kindly provided by Henri Jasper, Buck Institute for Research
for Aging. S2 cells were grown at 25 °C in Schneider’s Insect Medium
(Himedia) that was prepared according to the manufacturer’s instructions.
Chemicals and buffers
NDGA (Sigma), C646 (Sigma), A485 (Tocris), and Bafilomycin A1 (Adipogen)
were dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich), Chloroquine
(Biovision) was dissolved in water. Phosphate-buffered saline (PBS) was
purchased from Corning. Tris-buffered saline with Tween (TBST) buffer
(150mM NaCl, 0.01% (v/v) Tween-20, 50mM Tris-HCl buffer, pH 7.6) was
used for immunoblotting. Blocking buffer and primary antibody incubation
solution was 5% (w/v) BSA (Sigma), pH 7.0, in TBST. Secondary antibody
incubation buffer was 5% (w/v) blocking reagent (Sigma) in TBST.
Plasmids and transfection
HEK293T cells were transfected using TransIT-X2 (Mirus) reagent, following
the manufacturer’s instructions, and further treatments were carried out
48 h post transfection. Full-length wildtype p300, p300(Y1503A), and p300
(F1504A) were used for rescue experiments. Primers used for cloning are
listed in Supplementary Notes.
In vitro acetyltransferase activity assays
The activities of histone acetyltransferases, p300 and PCAF, were measured
using a fluorimetric assay kit, following the manufacturer’s instructions
(SensoLyte p300 Assay kit, SensoLyte PCAF Assay kit, Anaspec) using
appropriate dilutions of NDGA and anacardic acid. To measure the
inhibition of p300 and PCAF, appropriate dilutions of NDGA and anacardic
acid were prepared and added to the assay mixture. The manual in vitro
acetyltransferase assay kit was performed in reaction buffer (final
concentration; 40mM HEPES pH 7.5, 40 mM NaCl, 0.025% Triton X-100,
50 µM histone H3 peptide (amino acids 1–21), 40 nM p300 (Enzo Life
Science, BML-SE451), or 30 nM PCAF (Cayman Chemical, 10009115)) in
black 96-well microtiter plates (PerkinElmer, 6005320). Appropriate
dilutions of NDGA were prepared and added to the assay mixture. Enzyme
concentrations were evaluated to give a linear response between enzyme
concentration and initial velocity for each acetyltransferase tested.
Negative controls received assay buffer without peptide. Mixtures were
allowed to equilibrate for 5 min at room temperature, enzymatic reactions
were initiated by addition of acetyl-CoA (50 µM final concentration) and
incubated for 20min at 37 °C. Upon completion, reactions were stopped
with 1:1 volume of cold isopropanol and CPM (7-diethylamino-3-(4′-
maleimidylphenyl)-4-methylcoumarin, 12.5 µM final concentration). After
incubation for 15min at room temperature, plates were read in a
fluorescence microplate reader (POLARStar OPTIMA, BMG Labtech) at Ex=
390 nm/Em= 460 nm with a gain setting of 1391. For competition analysis,
concentrations of acetyl-CoA or histone H3 peptide were varied over
0.78–50 µM and 3.1–200 µM, respectively. Standard curves were generated
by preparing a twofold dilution series of freshly dissolved acetyl-CoA in
assay buffer covering a concentration range of 0–50 µM. Samples were
then mixed with isopropanol, reacted with CPM, and measured as
described above.
SDS-PAGE and immunoblotting
HEK293T cells were treated with NDGA for 24 h and lysed in lysis buffer
(20mM Tris-HCl pH 7.5, 150mM NaCl, 1 mM Na2EDTA, and 1mM EGTA, 1%
TritonX100) supplemented with complete EDTA-free protease inhibitor
cocktail (ROCHE) and PhosStop phosphatase inhibitor cocktail (ROCHE).
Polyacrylamide gels (10–15%) were used for the separation of total
proteins. Thirty micrograms of total proteins were transferred to 0.2 μm
nitrocellulose membranes using the BioRad blotting system. Histones were
extracted from HEK293T cells by EpiQuik Total Histone Extraction Kit
(Epigentek), following manufacturer’s instructions. One to five micrograms
of histone isolates was separated by Polyacrylamide gels (15%) and
transferred to 0.5-μm nitrocellulose membranes using the BioRad blotting
system. All membranes were blocked with blocking buffer (5% BSA in
TBST) and probed with primary and then secondary antibody. Antibodies
used are shown in Supplementary Notes. Lumi-Light Western Blotting
Substrate (ROCHE) or SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Fisher) were used for detection of the target proteins.
Chemiluminescence intensities were detected using the ChemiDoc
imaging system (BioRad) and quantified using Image J software (NIH).
β-actin levels were used to normalize the intensities of bands. For CETSA
curves, the band intensities were related to the intensities of the lowest
temperature for the control samples or drug-exposed sample. For the
ITDRFCETSA experiments, the band intensities were related to control
samples. All experiments were performed at least twice. All blots derive
from the same experiment and were processed in parallel.
Cellular thermal shift assay (CETSA)
For CETSA, HEK293T cells were freshly seeded the day before the
experiment. The day of experiment, equal numbers of cells were counted
by Moxi Mini automated cell counter (Orflo), and 0.6 × 10^6 cells per
temperature were seeded in T-25 cell culture flasks (VWR) in an appropriate
volume of culture medium. Cells were exposed to 100 µM NDGA or equal
volume DMSO for 3 h in an incubator with 5% CO2 and 37 °C. After the
incubation, cells were harvested, washed with PBS, and resuspended in
PBS supplemented with EDTA-free complete protease inhibitor cocktail
(ROCHE). Intact cells were divided into 100-μl aliquots and heated
individually at different temperatures for 3 min in a PCR machine (Thermal
cycler, BIO-RAD), followed by cooling for 2 min at room temperature. Cell
suspensions were freeze-thawed three times using liquid nitrogen, and the
soluble fraction was separated from the cell debris by centrifugation at
20,000 × g for 20 min at 4 °C. Supernatants were transferred to new micro
centrifuge tubes and analyzed by SDS-PAGE, followed by immunoblotting
analysis. Immunoblotting results were subjected to densitometry analysis
(ImageJ, NIH), and melting temperatures of p300-HAT, PCAF, GCN5, and
TIP60 were determined by Prism 7 software (GraphPad) using nonlinear
regression fit. The viability of the cells was assessed in triplicate by trypan
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blue exclusion. All CETSA experiments were performed at least as
triplicates.
Isothermal dose response fingerprint-cellular thermal shift assay
(ITDRFCETSA)
HEK293T cells were treated with different concentrations of NDGA and
prepared as described above. Intact cells were aliquoted (0.6 × 10^6 cells
per concentration) into PCR tubes and heated at 55 °C, where 35% of p300
HAT protein remained in the soluble fraction) for 3 min. Samples were
cooled down for an additional 2 min at room temperature and freeze-
thawed three times using liquid nitrogen. The soluble fraction was
separated by centrifugation at 20,000 × g for 20 min at 4 °C and subjected
to immunoblotting. ITDRFCETSA experiments were performed at least as
triplicates.
Flow cytometry
HeLa GFP-LC3 cells were analyzed by FACS as described.67 Briefly, cells
were collected by trypsin and washed with cold PBS. The pellets were
resuspended with 0.05% Saponin (diluted in PBS), vortexed briefly and
added six volumes of PBS to further dilute the detergent. Cells were
pelleted, resuspended with PBS and monitored by FACS (BD Bioscience).
Results were analyzed by FACSDiva 8.0.2 software.
Confocal microscopy
GFP-LC3 HeLa cells were seeded onto glass slide-chamber (Watson Bio
Lab) and treated with NDGA (30 μM) for 24 h and prepared for confocal
microscopy. Cells were fixed with 1.6% paraformaldehyde (Alfa Aesar) for
15min at RT and washed with PBS. Then, to stain nuclei, GFP-LC3 HeLa
cells were incubated with DAPI (Genetex) for 5 min at RT. After three PBS
washes, slides were prepared with mounting solution Tris-MWL 4-88
(Citifluor) for imaging. Samples were viewed on a temperature controlled
Zeiss 780 LSM confocal fluorescent microscope (488 nm for GFP, 405 nm
for DAPI, ×63/1.4 oil-immersion objective) in the Buck Institute for Research
on Aging Morphology Core. 16-bit images (2048 × 2048, C:2, Z:1, T:1) were
analyzed using Zen 2.3 2011 software (Zeiss) and Image J software (NIH).
GFP-LC3 puncta-positive cells were quantified using the Image J object
counter plug-in. Cells that contained 15 or more puncta per cell were
considered LC3-positive, and this threshold value (15 puncta/cell) was used
to determine the percentage of autophagic cells as described.68
Caenorhabditis elegans maintenance and lifespan assay
C. elegans hermaphrodites were maintained on nematode growth medium
(NGM) agar plates seeded with E. coli bacterial strain OP50 at 20 °C as
described.69 Strains used in this study were wildtype Bristol N2 and
MAH215 (sqIs11 [lgg-1p::mCherry::GFP::lgg-1+ rol-6] rollers. Wildtype N2
Bristol worms were synchronized by a 2-h egg lay from gravid adult
hermaphrodites, and the eggs were transferred to NGM plates containing
100 μM NDGA with a bacterial OP50 lawn at 20 °C. Worms were scored as
dead when they no longer responded to gentle prodding with a platinum
wire. The lifespan of an individual was defined as the time elapsed from
when it was placed onto the fresh NGM plate (t= 0) to when it was scored
as dead. Nematodes that crawled off plates during the assay were
excluded from calculations.
OP50 growth assay
E. coli OP50 culture was grown in LB overnight at 37 °C shaker (200 rpm).
The day after, the culture was diluted 1:1000 in LB containing either
100 μM NDGA or the same volume of DMSO. The absorbance at 595 nm
was measured by SpectraMax i3X every hour. Experiments were performed
in eight technical replicates in a total of three independent experiments
and plotted as time-dependent growth curve.
Mounting worms and imaging
NDGA (100 μM) was prepared in sterile water and added to the top of NGM
plates seeded with a bacterial OP50 lawn. On their first day of adulthood,
synchronized population of worms were transferred to either DMSO
control or NDGA-treated plates for experimental analysis. Microscopic
slides containing pads of 2% agarose (Sigma) were prepared 30min before
mounting worms. Around 2–5 μl of 2 mM levamisole (Sigma) was pipetted
out on the center of the agarose pads. Worms were transferred to the
levamisole drop, and a cover slip was placed on top before imaging.
Lysotracker red staining
Synchronized day-1 adult N2 worms were transferred to DMSO control or
NDGA-treated plates for 24 h at 20 °C. On day 2, worms were transferred to
OP50-seeded plates treated with NDGA and containing 1 μM LysoTracker
Red DND-99 (Molecular Probes) for 24 h at 20 °C. After 24 h, worms were
picked and washed in a fresh drop of 1X M9 medium and mounted on 2%
agarose pad slides for microscopic visualization. Worm images were taken
in a Zeiss Imager Z1 fluorescence microscope using rhodamine filters.
Image analysis was performed by measuring mean LysoTracker fluores-
cence of each worm using Image J (NIH) software.
Tandem-tagged LGG-1 reporter imaging
MAH215 worms were synchronized and transferred to DMSO control or
NDGA-treated plates on day 1 of adulthood as above. After 2 or 24 h,
worms were imaged using GFP and rhodamine filters on a Zeiss
fluorescence microscope. For each worm, we quantified the number of
mCherry-only puncta (i.e., autolysosmes (AL) (the total number of mCherry-
positive punctae− the number of GFP-intensity) as described.
Worm protein extraction
Synchronized day-1 adult N2 worms were transferred to DMSO control or
NDGA treated plates for 24 h at 20 °C. One hundred worms from each
treatment condition were collected in 1X M9 solution. Worms were
washed twice and suspended in RIPA lysis buffer. Worm pellets were
sonicated for 10 cycles at maximum intensity in Bioruptor sonicator
(Diagenode). Lysate was centrifuged at 1000 g for 1 min, and clear protein
lysate was used for immunoblotting.
Statistical analysis
Dose-response analysis of histone acetylation in cells was analyzed by
nonlinear regression fit to Y= 100/(1+ 10 (Log IC50 – X)*H), where H=Hill
slope (variable). IC50 values represent the concentration of NDGA that
inhibits 50% of the occurrence of acetylation of the target residue. The
experiments in which wildtype and mutant p300 plasmids used were
subjected to correlation analysis by a Pearson correlation. CETSA data were
expressed as means ± SD. Band intensities from independent experiments
(n ≥ 2) were plotted using nonlinear regression fit (variable slope).
ITDRFCETSA data were fitted using a sigmoidal (variable slope) curve fit.
Multiple confocal microscopy images (n ≥ 100 cells per condition) were
analyzed, and data were expressed as means ± SD. P values were
determined by unpaired, two-tailed Student’s t tests. (*p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001). P values in lifespan curves were
calculated using the log-rank (Mantel–Cox) test. In the tandem-tagged
LGG-1 reporter imaging, the average puncta were calculated, and data
were analyzed using one-way analysis of variance ANOVA. All calculations
were performed using Prism 7 (GraphPad) software.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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